June 2013 archive

Jun 28

Carin Canale-Theakston

Carin Canale-Theakston is the president and founder of Canale Communications Inc. In her role as president, Carin works closely with client teams, having provided senior level strategy to more than 125 life science companies of all shapes and sizes ranging from pre-series A financing to billion dollar public companies such as Amgen and Johnson & …

Continue reading »

Jun 27

Gautam Kollu

Vice President (Commercial Operations), Exelixis Gautam KolluGautam Kollu is VP of Commercial at Exelixis, where his team is charged with distribution, marketing and customer management efforts for cabozantinib, a novel oncology therapeutic. Most recently, he oversaw the strategic marketing initiatives for Exelixis’s portfolio of oncology compounds. Previously, Gautam worked at Genentech, where he led a …

Continue reading »

Jun 13

Building a Biotech Business: The Big Picture & The Nitty Gritty

Campbell Alliance Deal Makers Intention Survey Thursday June 13th from 10:15am-11:30am Following a highly successful Super Session at the BIO International Convention, Campbell Alliance is pleased to present the results of its fifth annual Dealmakers’ Intentions Survey, the only forward-looking measure of deal-making activity in the pharmaceutical and biotech industries. While there are many quality …

Continue reading »

Jun 13

The Future, 2030

The year is 2030 and biotechnology is recognized as one of humankind’s greatest intellectual enterprises. Cancer is a manageable disease and world hunger has largely been alleviated. The life sciences industry has been an investment hub for private and public investors for more than a decade and public opinion on biotechnology is at an all-time …

Continue reading »

Jun 13

The Future of Healthcare: It’s Digital, It’s Connected and It’s Consumer-Driven

A look at the Future of Digital Connected Health and Wellness Care Thursday June 13th from 10:15am-11:30am To set the stage for the rest of the track, our experts will address a range of topics to help us look at the future of digital health and wellness care from a scientific, technical, and consumer perspective. …

Continue reading »

Jun 13

Capital Case Studies

Finding the Money: Where to Look and What Sells Thursday June 13th from 11:45am-1:00pm There’s money available for new and cash hungry private companies who know where to look and bring the right investment proposition, but it’s not going to be easy or quick. Get the scoop on who is investing or re-investing, how much …

Continue reading »

Jun 13

Life Science Speed Dating: Finding the Diamond Ring from VC and Pharma

Pharmaceutical Business Development Investing Thursday June 13th from 10:15am-11:30am Moderator: Brian O’Callaghan, President & CEO, Sangart Confirmed Panelists: Adam Keeney, VP, Head of Transactions, Johnson & Johnson West Coast Innovation Centers John McDonald, Vice President, Co-Head of Business Development and Mergers & Acquisitions, Biogen Idec Lisa Mendoza, Associate Director, Bayer Healthcare John Tupman, Vice President, …

Continue reading »

Jun 12

J. Craig Venter, Ph.D.

J. Craig Venter, Ph.D.J. Craig Venter, Ph.D., is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. He is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 300 scientists and staff dedicated to human, microbial, plant, …

Continue reading »

Jun 10

Francois Meurgey

President, Oukelos Consulting Francois Meurgey is President of Oukelos, a consultancy based in Brussels, and was formerly Vice President of Marketing at UCB in Brussels. His prior appointments include marketing and strategy positions at Merck and Pharmacia (now Pfizer). He holds an MBA from New York University.